Skip to Main Content

Paper Details

VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types-A Meta-Analysis.
0
2023
Cancer, Liver, Liver Metastases, Patients, VEGF, cancers, liver metastases, liver metastasis, patients, vascular endothelial growth factor
Author NameAffiliation
Richard A ScolyerMelanoma Institute Australia, The University of Sydney
Richard A ScolyerThe University of Sydney
Richard A ScolyerThe University of Sydney
Richard A ScolyerRoyal Prince Alfred Hospital
Richard A Scolyer
Georgina V LongMelanoma Institute Australia, The University of Sydney
Georgina V LongThe University of Sydney
Georgina V LongThe University of Sydney
Georgina V LongRoyal North Shore Hospital
Georgina V LongMater Hospital
  • 1 - 10

Datasets

Release 1.2